Vulinacimab
Product Specifications
CAS Number
2250342-36-8
Target
VEGFR
Related Pathways
Tyrosine Kinase/Adaptors|||Angiogenesis
Bioactivity
Vulinacimab (HLX-06), an anti-VEGFR-2 monoclonal antibody (mAb), plays a pivotal role in cancer research due to VEGFR-2's significant involvement in angiogenesis, as well as the proliferation, survival, migration, and differentiation of endothelial cells, processes critical for tumor growth where VEGFR-2 is overexpressed [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
46721151 3x 1.0 µg DNA
TIMM8B CRISPR All-in-one AAV vector set (with saCas9)(Human)
Ask
View Details 